SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-003936
Filing Date
2024-01-08
Accepted
2024-01-08 08:08:00
Documents
15
Period of Report
2024-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d109329d8k.htm   iXBRL 8-K 32774
2 EX-99.1 d109329dex991.htm EX-99.1 30407
6 GRAPHIC g109329g0106130658285.jpg GRAPHIC 2767
7 GRAPHIC g109329g0108013926807.jpg GRAPHIC 2384
  Complete submission text file 0001193125-24-003936.txt   208993

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20240103.xsd EX-101.SCH 2888
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20240103_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20240103_pre.xml EX-101.PRE 11286
9 EXTRACTED XBRL INSTANCE DOCUMENT d109329d8k_htm.xml XML 3396
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1215
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 24518435
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)